Resapp Health Limited (ASX:RAP) was up 110.1% on Tuesday . The stock traded as high as A$0.17 ($0.12) and last traded at A$0.15 ($0.10), approximately 17,329,548 shares traded hands during mid-day trading. The stock had previously closed at A$0.07 ($0.05).
The stock has a market capitalization of $116.17 million and a P/E ratio of -17.78. The company has a debt-to-equity ratio of 8.24, a current ratio of 2.62 and a quick ratio of 2.56. The stock’s 50-day moving average price is A$0.19.
About Resapp Health (ASX:RAP)
ResApp Health Limited develops digital healthcare solutions to assist doctors and allow patients to diagnose and manage respiratory disease. The company delivers mobile software apps in various clinical settings, including telehealth, emergency, urgent care, and primary care. Its technology uses sound to diagnose respiratory diseases, including pneumonia, bronchiolitis, bronchitis, chronic obstructive pulmonary disease, and asthma.
Featured Article: Neutral Rating
Receive News & Ratings for Resapp Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resapp Health and related companies with MarketBeat.com's FREE daily email newsletter.